Eccles SA - Search Results

1

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.

Beloueche-Babari M, Box C, Arunan V, Parkes HG, Valenti M, De Haven Brandon A, Jackson LE, Eccles SA, Leach MO. Beloueche-Babari M, et al. Among authors: eccles sa. Br J Cancer. 2015 Mar 31;112(7):1206-14. doi: 10.1038/bjc.2015.86. Br J Cancer. 2015. PMID: 25742484 Free PMC article.

2

Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer.

Kirby AM, A'Hern RP, D'Ambrosio C, Tanay M, Syrigos KN, Rogers SJ, Box C, Eccles SA, Nutting CM, Harrington KJ. Kirby AM, et al. Among authors: eccles sa. Br J Cancer. 2006 Mar 13;94(5):631-6. doi: 10.1038/sj.bjc.6602999. Br J Cancer. 2006. PMID: 16495923 Free PMC article. Clinical Trial.

3

Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns.

Moore AS, Faisal A, Gonzalez de Castro D, Bavetsias V, Sun C, Atrash B, Valenti M, de Haven Brandon A, Avery S, Mair D, Mirabella F, Swansbury J, Pearson AD, Workman P, Blagg J, Raynaud FI, Eccles SA, Linardopoulos S. Moore AS, et al. Among authors: eccles sa. Leukemia. 2012 Jul;26(7):1462-70. doi: 10.1038/leu.2012.52. Epub 2012 Feb 22. Leukemia. 2012. PMID: 22354205 Free PMC article.

4

Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity.

Chan F, Sun C, Perumal M, Nguyen QD, Bavetsias V, McDonald E, Martins V, Wilsher NE, Raynaud FI, Valenti M, Eccles S, Te Poele R, Workman P, Aboagye EO, Linardopoulos S. Chan F, et al. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3147-57. doi: 10.1158/1535-7163.MCT-07-2156. Mol Cancer Ther. 2007. PMID: 18089709

5

Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.

O-charoenrat P, Rhys-Evans P, Eccles SA. O-charoenrat P, et al. Among authors: eccles sa. Cancer. 2001 Aug 1;92(3):556-68. doi: 10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>3.0.co;2-q. Cancer. 2001. PMID: 11505400

6

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: eccles sa. Cancer Res. 2000 Feb 15;60(4):1121-8. Cancer Res. 2000. PMID: 10706134

7

Guidelines for the welfare and use of animals in cancer research.

Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA; Committee of the National Cancer Research Institute. Workman P, et al. Among authors: eccles sa. Br J Cancer. 2010 May 25;102(11):1555-77. doi: 10.1038/sj.bjc.6605642. Br J Cancer. 2010. PMID: 20502460 Free PMC article.

8

Pre-clinical quantitative imaging and mouse-specific dosimetry for ¹¹¹In-labelled radiotracers.

Denis-Bacelar AM, Cronin SE, Da Pieve C, Paul RL, Eccles SA, Spinks TJ, Box C, Hall A, Sosabowski JK, Kramer-Marek G, Flux GD. Denis-Bacelar AM, et al. Among authors: eccles sa. EJNMMI Res. 2016 Dec;6(1):85. doi: 10.1186/s13550-016-0238-z. Epub 2016 Nov 25. EJNMMI Res. 2016. PMID: 27885618 Free PMC article.

9

Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues.

Sharp SY, Prodromou C, Boxall K, Powers MV, Holmes JL, Box G, Matthews TP, Cheung KM, Kalusa A, James K, Hayes A, Hardcastle A, Dymock B, Brough PA, Barril X, Cansfield JE, Wright L, Surgenor A, Foloppe N, Hubbard RE, Aherne W, Pearl L, Jones K, McDonald E, Raynaud F, Eccles S, Drysdale M, Workman P. Sharp SY, et al. Mol Cancer Ther. 2007 Apr;6(4):1198-211. doi: 10.1158/1535-7163.MCT-07-0149. Mol Cancer Ther. 2007. PMID: 17431102 Free article.

10

Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

O-charoenrat P, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: eccles sa. Clin Exp Metastasis. 1999;17(7):631-9. doi: 10.1023/a:1006751016860. Clin Exp Metastasis. 1999. PMID: 10845563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters